NDC 63323-651-23 - ADENOSINE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-651
- Requested NDC
- 63323-651-23
- Package NDCs from labels
- 63323-651-00, 63323-651-02, 63323-651-01, 63323-651-04, 63323-651-20, 63323-651-30, 63323-651-21, 63323-651-89, 63323-651-23, 63323-651-90
- Manufacturer
- Henry Schein, Inc.
- Effective date
- 2026-10-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| adenosine injection, solution - Henry Schein, Inc. | Henry Schein, Inc. | 2026-10-22 | HUMAN PRESCRIPTION DRUG LABEL |
| ADENOSINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-05-09 | HUMAN PRESCRIPTION DRUG LABEL |
| ADENOSINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2023-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
| ADENOSINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2023-06-26 | HUMAN PRESCRIPTION DRUG LABEL |
| Adenosine - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-04-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Adenosine - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-03-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Adenosine Injection USP | REMEDYREPACK INC. | 2020-04-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Adenosine - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | 2018-12-04 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-651-00 | Adenosine | 2 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 2 | 4 | |
| 63323-651-01 | Adenosine | 4 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 4 | 4 | |
| 63323-651-02 | Adenosine | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 4 | |
| 63323-651-04 | Adenosine | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 4 | |
| 63323-651-20 | Adenosine | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 3 | |
| 63323-651-20 | Adenosine | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 3 | |
| 63323-651-30 | Adenosine | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 3 | |
| 63323-651-30 | Adenosine | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 3 | |
| 63323-651-21 | Adenosine | 2 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 2 | 1 | |
| 63323-651-23 | Adenosine | 4 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 4 | 1 | |
| 63323-651-89 | Adenosine | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 1 | |
| 63323-651-90 | Adenosine | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-651 | ADENOSINE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 4 | Current NDC, Legacy NDC, 4 package rows | 20230830_e660f71c-35ed-438e-8505-4538f5e925a2.zip |
| 63323-651 | ADENOSINE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | Current NDC, Legacy NDC, 4 package rows | 20230406_f88a8cf7-d354-42f2-b5e8-ba002fcfc460.zip |
| 63323-651 | ADENOSINE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | Current NDC, Legacy NDC, 4 package rows | 20190328_6785cf30-360f-409b-a4b2-fc910728f01f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-651-00 | ML - Milliliter | 63323-651 | e973a2d1-989f-491d-a079-52aafba7ffff | 1 | 2024-06-10 |
| 63323-651-01 | ML - Milliliter | 63323-651 | 1bac6cc0-c696-47d2-983e-f5f0324be57c | 1 | 2024-09-09 |
| 63323-651-02 | ML - Milliliter | 63323-651 | 78983a12-3bfa-4b89-bdbb-da5fed8cabfa | 1 | 2012-07-24 |
| 63323-651-04 | ML - Milliliter | 63323-651 | 3a1f0bc2-e05e-4e83-aa3e-f674a66b447a | 1 | 2012-07-24 |
| 63323-651-20 | ML - Milliliter | 63323-651 | cf3c7cc6-ed97-4cba-8923-3d3ad265245f | 1 | 2018-06-11 |
| 63323-651-21 | ML - Milliliter | 63323-651 | e457f5a3-0292-4515-b4e1-9211cfa48312 | 1 | 2019-04-11 |
| 63323-651-23 | ML - Milliliter | 63323-651 | fd358bc0-e9b9-4b9d-ae64-5fd92d987f7e | 1 | 2019-04-11 |
| 63323-651-30 | ML - Milliliter | 63323-651 | 847bb02f-e73c-4e81-9cb2-8fa5cd9565b0 | 1 | 2018-06-11 |
| 63323-651-89 | ML - Milliliter | 63323-651 | 2aab18ab-f841-43da-8c3f-46ba9dbbe611 | 1 | 2019-04-11 |
| 63323-651-90 | ML - Milliliter | 63323-651 | 9644624d-c0c1-4f8a-af80-b04327c95dca | 1 | 2019-04-11 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ADENOSINE | ACTIVE INGREDIENT | K72T3FS567 | ADENOSINE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| ADENOSINE | ACTIVE MOIETY | K72T3FS567 | ADENOSINE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | ADENOSINE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Walgreens Sterile Soothing Eye Wash | PURIFIED WATER | Walgreens | a62e3294-abd6-48dc-81b1-62a809bdc968 | 2026-10-19 | Warnings | 059QF0KO0R |
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | CODAN US CORPORATION | aa06e286-75c6-4d7a-959f-6008d38aa6e5 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | 28f79c75-82d2-4912-81fc-a723b5ccf4c1 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | SOLA Pharmaceuticals, LLC | 4d0bfd28-460a-48ba-bd17-cf75e56d62f4 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| MEIJER Saline | NASAL | MEIJER | a5c6d800-078a-4b66-9d4c-cf3c53f5c138 | 2026-10-05 | Warnings | 451W47IQ8X |
| Personal CARE Saline Nasal | SODIUM CHLORIDE | Delta Brands Inc. | 5ccaf7a1-6891-eac4-e063-6294a90a829f | 2026-10-02 | Warnings | 451W47IQ8X |
| Dextrose And Sodium Chloride | DEXTROSE AND SODIUM CHLORIDE | B. Braun Medical Inc. | 8e6569ce-9714-497f-a94b-c6975c1d76f6 | 2026-09-28 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride Hypertonicity Ophthalmic | SODIUM CHLORIDE | Rugby Laboratories | 7546770d-bc12-44b8-9fe0-fc3f5e1d12d1 | 2026-09-24 | Warnings | 451W47IQ8X |
| Rugby Eye Wash | WATER, PURIFIED | Rugby Laboratories | 1fee974b-4c29-4965-bd3d-da5e219eb13a | 2026-09-24 | Warnings | 059QF0KO0R |
| Sodium Chlorode Hypertonicity Ophthalmic Solution | SODIUM CHLORIDE | Rugby Laboratories | 822d25c0-71b3-421d-b702-4cded0c4ca32 | 2026-09-23 | Warnings | 451W47IQ8X |
| BURBLE | SODIUM CHLORIDE | LETS BURBLE, INC. | 17f48d4f-907c-3829-e063-6394a90ab202 | 2026-09-22 | Warnings | 451W47IQ8X |
| Sterile Water | WATER | B. Braun Medical Inc. | f4284eb6-e553-46d4-90d8-efc80a90a480 | 2026-09-18 | Warnings, Adverse reactions | 059QF0KO0R |
| HEB Saline | NASAL | HEB | 520e20a3-1e16-4cbd-9da3-948747f4f51d | 2026-09-18 | Warnings | 451W47IQ8X |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.